These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16043978)

  • 1. The role of brain natriuretic peptide in systolic heart failure.
    White RM
    Dimens Crit Care Nurs; 2005; 24(4):171-4. PubMed ID: 16043978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurohormonal effects of furosemide withdrawal in elderly heart failure patients with normal systolic function.
    van Kraaij DJ; Jansen RW; Sweep FC; Hoefnagels WH
    Eur J Heart Fail; 2003 Jan; 5(1):47-53. PubMed ID: 12559215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-natriuretic peptide in the management of heart failure.
    Armstrong J; Graber MA
    JAAPA; 2003 Jun; 16(6):35-9, 44. PubMed ID: 14968503
    [No Abstract]   [Full Text] [Related]  

  • 4. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance.
    Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A
    Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain natriuretic peptide (BNP) level is closely related to the extent of left ventricular sympathetic overactivity in chronic ischemic heart failure.
    Sakata K; Iida K; Mochiduki N; Nakaya Y
    Intern Med; 2009; 48(6):393-400. PubMed ID: 19293536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Type B natriuretic peptide. Role in heart failure physiopathology, diagnosis, and prognosis].
    Bettencourt P; Azevedo A
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II95-104. PubMed ID: 15222253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natriuretic peptides in cardiovascular medicine.
    Munagala VK; Burnett JC; Redfield MM
    Curr Probl Cardiol; 2004 Dec; 29(12):707-69. PubMed ID: 15550914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurohormonal activation in heart failure with reduced ejection fraction.
    Hartupee J; Mann DL
    Nat Rev Cardiol; 2017 Jan; 14(1):30-38. PubMed ID: 27708278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of natriuretic peptides in heart failure].
    Ancona R; Limongelli G; Pacileo G; Miele T; Rea A; Roselli T; Masarone D; Messina S; Palmieri R; Golia E; Iacomino M; Gala S; Calabrò P; Di Salvo G; Calabrò R
    Minerva Med; 2007 Oct; 98(5):591-602. PubMed ID: 18043566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options of Angiotensin Receptor Neprilysin inhibitors (ARNis) in chronic heart failure with reduced ejection fraction: Beyond RAAS and sympathetic nervous system inhibition.
    Volterrani M; Iellamo F; Senni M; Piepoli MF
    Int J Cardiol; 2017 Jan; 226():132-135. PubMed ID: 27184730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.
    Fajardo J; Heywood JT; Patterson JH; Adams K; Chow SL
    Expert Rev Cardiovasc Ther; 2015; 13(7):743-51. PubMed ID: 26028173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aerobic training decreases B-type natriuretic peptide expression and adrenergic activation in patients with heart failure.
    Passino C; Severino S; Poletti R; Piepoli MF; Mammini C; Clerico A; Gabutti A; Nassi G; Emdin M
    J Am Coll Cardiol; 2006 May; 47(9):1835-9. PubMed ID: 16682309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressed Corin Levels Indicate Early Systolic Dysfunction Before Increases of Atrial Natriuretic Peptide/B-Type Natriuretic Peptide and Heart Failure Development.
    Tripathi R; Wang D; Sullivan R; Fan TH; Gladysheva IP; Reed GL
    Hypertension; 2016 Feb; 67(2):362-7. PubMed ID: 26667411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous B-type natriuretic peptide: a limb of the regulatory response to acutely decompensated heart failure.
    Hobbs RE; Mills RM
    Clin Cardiol; 2008 Sep; 31(9):407-12. PubMed ID: 18781599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the renal and neurohormonal effects of B-type natriuretic peptide.
    Burger AJ
    Congest Heart Fail; 2005; 11(1):30-8. PubMed ID: 15722668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.
    Kjaer A; Hesse B
    Clin Physiol; 2001 Nov; 21(6):661-72. PubMed ID: 11722473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of defective B-type natriuretic peptide.
    Menon SG; Mills RM; Schellenberger U; Saqhir S; Protter AA
    Clin Cardiol; 2009 Dec; 32(12):E36-41. PubMed ID: 20014209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
    Valle R; Aspromonte N; Feola M; Milli M; Canali C; Giovinazzo P; Carbonieri E; Ceci V; Cerisano S; Barro S; Milani L
    J Card Fail; 2005 Sep; 11(7):498-503. PubMed ID: 16198244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide.
    Miller WL; Burnett JC; Hartman KA; Henle MP; Burritt MF; Jaffe AS
    Am J Cardiol; 2005 Sep; 96(6):837-41. PubMed ID: 16169373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and therapeutic utility of B-type natriuretic peptide in patients with renal insufficiency and decompensated heart failure.
    McCullough PA; Kuncheria J; Mathur VS
    Rev Cardiovasc Med; 2003; 4 Suppl 7():S3-S12. PubMed ID: 14668695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.